explore -WSS

explore

author：leisure time 2025-09-28 23:47:44 - browse：5

An army of wooden figures under blue and pink lighting — biotech coverage from STAT — Adobe

Biotech startup ReNAgade Therapeutics is cutting staff just seven months after raising the largest Series A round in the industry this year.

ReNAgade launched in May with hopes of becoming a one-stop shop for medicines targeting RNA, the genetic blueprints that cells use to make proteins instrumental in numerous diseases. These types of medicines are in high demand following the advent of mRNA vaccines for Covid and RNA-silencing therapies made by companies like Alnylam Pharmaceuticals.

ReNAgade was able to capitalize on that excitement when it raised a $300 million Series A round led by MPM Capital’s BioImpact Capital and F2 Ventures. But in recent days, the company decided to lay off around 10% of its 100-person team, according to a company statement and former employees’ posts on social media.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Emergency medicine has repudiated 'excited delirium.' Now what?

WSS

Paying for Covid pills will soon shift to insurers

FDA has safety concerns on CRISPR

A disappointing year of Humira biosimilars

Readout LOUD podcast: How biotech is using artificial intelligence

The pink breast cancer awareness ribbon needs a redesign

Meta's Zuckerberg and Chan on track to put $50 billion into science

leisure time

explore

focus

The cancer drug shortage isn’t new — and neither are the solutions

Maker of FluMist seeks to allow at

Novavax promises a turnaround & Lilly roils the obesity market

Readout Newsletter: New research from Sanofi, Regeneron, etc.

Peter Hotez and the public health issue of online harassment

Meta's Zuckerberg and Chan on track to put $50 billion into science

Wildfire smoke exposes gaps in outdoor worker protections

Industry veterans launch new biotech VC with $310M

Virginia high school admissions case could be legal follow

Biden report: The neurospychology of memory and aging

entertainment

Chimpanzees, like humans and whales, get menopause: Study

Meta's Zuckerberg and Chan on track to put $50 billion into science

To avoid data mishandling cases, universities eye AI and other tools

Key House Republican on health care plans exit from Congress

Emergency medicine has repudiated 'excited delirium.' Now what?

To avoid data mishandling cases, universities eye AI and other tools

entertainment

leisure time

knowledge

hotspot